Results 51 to 60 of about 3,279 (166)

Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthetic DMARDs

open access: yesInternational Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.
ABSTRACT Objectives Evidence indicates that hematological indices, such as neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammation index (SII), and neutrophil‐to‐hemoglobin and lymphocyte (NHL), are valuable for assessing disease activity in rheumatoid arthritis (RA).
Jyun‐Pei Jhou   +4 more
wiley   +1 more source

Sichtenmechanismen für SDAI/EXPRESS-Datenbanken

open access: yes, 1996
In den letzten Jahren hat es eine stürmische Entwicklung auf dem Gebiet der objektorientierten Datenbanksysteme gegeben. Von ihnen erhofft man sich eine bessere Wiederverwendbarkeit einzelner Softwarekomponenten (im Sinne des objektorientierten ...
Mayer, Ralph
core   +1 more source

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis

open access: yesТерапевтический архив, 2013
AIM: To evaluate the impact of tocilizumab (TCZ) therapy on the level of matrix metalloproteinase-3 (MMP-3) 4, 24, and 48 weeks after treatment initiation in relation to the clinical efficiency of TCZ therapy by the Disease Activity Score (DAS28), the ...
A S Avdeeva   +5 more
doaj  

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 615-629, June 2026.
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail   +7 more
wiley   +1 more source

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis

open access: yesFrontiers in Immunology, 2020
Background: TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve remission (REM).Objective: To analyze baseline ...
Eulalia Rodríguez-Martín   +17 more
doaj   +1 more source

The Effect of an Autoimmune Protocol (AIP) Diet in Adults With Rheumatoid Arthritis: A Single Arm Crossover Pilot Feasibility Study

open access: yesMusculoskeletal Care, Volume 24, Issue 2, June 2026.
ABSTRACT Background Individuals with rheumatoid arthritis (RA) often ask whether dietary changes or food exclusions can reduce symptoms. The Autoimmune Protocol (AIP) diet, an elimination‐based approach, is popular on social media, with anecdotal reports of benefit, but lacks clinical evaluation in RA.
Julianne J. McNeill   +3 more
wiley   +1 more source

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry

open access: yesTherapeutic Advances in Musculoskeletal Disease, 2022
Background: Biologic or targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD) are widely used for treatment of rheumatoid arthritis (RA), enabling patients to better achieve remission.
Jung Hee Koh   +4 more
doaj   +1 more source

Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis

open access: yesRheumatology &Autoimmunity, Volume 6, Issue 2, Page 94-104, June 2026.
Patient‐reported outcomes (PROs) were compared among rheumatoid arthritis patients who maintained low disease activity or remission for at least 6 months based on the disease‐modifying antirheumatic drug (DMARD)administered. Even with comparable disease activity, methotrexate (MTX) group, biological/targeted synthetic DMARDs (b/tsDMARDs), particularly ...
Masafumi Sugiyama   +4 more
wiley   +1 more source

Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study. [PDF]

open access: yesPLoS ONE, 2015
Our goal is to study the correlations among gray-scale seven-joint ultrasound score (GS-US7), power Doppler seven-joint ultrasound score (PD-US7), disease activity score-28 joints (DAS28), simplified disease activity index (SDAI) and clinical disease ...
Rafael Mendonça da Silva Chakr   +7 more
doaj   +1 more source

PM10 Impairs CD56dim NK Cell Cytotoxicity via FNBP1 Suppression to Exacerbate Rheumatoid Arthritis: Insights from Multimodal Multi‐Omics

open access: yesAdvanced Science, Volume 13, Issue 19, 2 April 2026.
This study, through multi‐omics approaches and animal models, revealed that air pollutant PM10 exacerbates the progression of rheumatoid arthritis (RA) by suppressing FNBP1 expression and impairing the cytotoxic function of CD56dim NK cells. The “PM10–FNBP1–NK cells” axis provided novel insights into the environmental pathogenesis of RA and suggested ...
Runhan Zhao   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy